RELATED CONTENT
NEWS
- Mixed Phase III results for Erbitux in first-line colorectal cancer
- Personalised medicine approach may hold benefit for late-stage cancer patients
- AstraZeneca withdraws US and EU filings for Zactima in lung cancer
- New US labelling for Erbitux and Vectibix recommends against their use for large subset of colorectal cancer patients
COMMENT
Other Informa Comment
EVENTS
17 March 2010
Berlin, Germany
17 March 2010
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009


